Report for Han HJ

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (10)

Title : Prenatal glucocorticoid exposure selectively impairs neuroligin 1-dependent neurogenesis by suppressing astrocytic FGF2-neuronal FGFR1 axis - Choi_2022_Cell.Mol.Life.Sci_79_294
Author(s) : Choi GE , Chae CW , Park MR , Yoon JH , Jung YH , Lee HJ , Han HJ
Ref : Cell Mol Life Sciences , 79 :294 , 2022
Abstract : Choi_2022_Cell.Mol.Life.Sci_79_294
ESTHER : Choi_2022_Cell.Mol.Life.Sci_79_294
PubMedSearch : Choi_2022_Cell.Mol.Life.Sci_79_294
PubMedID: 35562616

Title : A Multinational, Multicenter, Randomized, Double-Blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease - Han_2022_J.Clin.Neurol_18_428
Author(s) : Han HJ , Park MY , Park KW , Park KH , Choi SH , Kim HJ , Yang DW , Ebenezer E , Yang YH , Kewalram GM , Han SH
Ref : J Clin Neurol , 18 :428 , 2022
Abstract : Han_2022_J.Clin.Neurol_18_428
ESTHER : Han_2022_J.Clin.Neurol_18_428
PubMedSearch : Han_2022_J.Clin.Neurol_18_428
PubMedID: 35796268

Title : Mixture of Phlorotannin and Fucoidan from Ecklonia cava Prevents the Abeta-Induced Cognitive Decline with Mitochondrial and Cholinergic Activation - Han_2021_Mar.Drugs_19_
Author(s) : Han HJ , Park SK , Kang JY , Kim JM , Yoo SK , Kim DO , Kim GH , Heo HJ
Ref : Mar Drugs , 19 : , 2021
Abstract : Han_2021_Mar.Drugs_19_
ESTHER : Han_2021_Mar.Drugs_19_
PubMedSearch : Han_2021_Mar.Drugs_19_
PubMedID: 34436273

Title : Immature Persimmon Suppresses Amyloid Beta (Abeta) Mediated Cognitive Dysfunction via Tau Pathology in ICR Mice - Yoo_2021_Curr.Issues.Mol.Biol_43_405
Author(s) : Yoo SK , Kim JM , Lee U , Kang JY , Park SK , Han HJ , Park HW , Kim HJ , Kim CW , Kim MJ , Heo HJ
Ref : Curr Issues Mol Biol , 43 :405 , 2021
Abstract : Yoo_2021_Curr.Issues.Mol.Biol_43_405
ESTHER : Yoo_2021_Curr.Issues.Mol.Biol_43_405
PubMedSearch : Yoo_2021_Curr.Issues.Mol.Biol_43_405
PubMedID: 34205542

Title : Green Tea Seed Oil Suppressed Abeta1(-)42-Induced Behavioral and Cognitive Deficit via the Abeta-Related Akt Pathway - Kim_2019_Int.J.Mol.Sci_20_
Author(s) : Kim JM , Park SK , Kang JY , Park SB , Yoo SK , Han HJ , Cho KH , Kim JC , Heo HJ
Ref : Int J Mol Sci , 20 : , 2019
Abstract : Kim_2019_Int.J.Mol.Sci_20_
ESTHER : Kim_2019_Int.J.Mol.Sci_20_
PubMedSearch : Kim_2019_Int.J.Mol.Sci_20_
PubMedID: 30991755

Title : Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease - Choi_2018_J.Alzheimers.Dis_66_1721
Author(s) : Choi H , Yang Y , Han HJ , Jeong JH , Park MY , Kim YB , Jo KD , Choi JY , Kang KH , Kang H , Kwon DY , Yoo BG , Lee HJ , Shin BS , Jeon SM , Kwon OD , Kim JS , Lee SJ , Kim Y , Park TH , Kim YJ , Yang HJ , Park HY , Shin HE , Lee JS , Jung YH , Lee AY , Shin DI , Shin KJ , Park KH
Ref : J Alzheimers Dis , 66 :1721 , 2018
Abstract : Choi_2018_J.Alzheimers.Dis_66_1721
ESTHER : Choi_2018_J.Alzheimers.Dis_66_1721
PubMedSearch : Choi_2018_J.Alzheimers.Dis_66_1721
PubMedID: 30452413

Title : Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial - Park_2017_PLoS.One_12_e0182123
Author(s) : Park KW , Kim EJ , Han HJ , Shim YS , Kwon JC , Ku BD , Park KH , Yi HA , Kim KK , Yang DW , Lee HW , Kang H , Kwon OD , Kim S , Lee JH , Chung EJ , Park SW , Park MY , Yoon B , Kim BC , Seo SW , Choi SH
Ref : PLoS ONE , 12 :e0182123 , 2017
Abstract : Park_2017_PLoS.One_12_e0182123
ESTHER : Park_2017_PLoS.One_12_e0182123
PubMedSearch : Park_2017_PLoS.One_12_e0182123
PubMedID: 28786987

Title : Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease - Han_2014_Eur.Neurol_73_23
Author(s) : Han HJ , Kwon JC , Kim JE , Kim SG , Park JM , Park KW , Park KC , Park KH , Moon SY , Seo SW , Choi SH , Cho SJ
Ref : Eur Neurol , 73 :23 , 2014
Abstract : Han_2014_Eur.Neurol_73_23
ESTHER : Han_2014_Eur.Neurol_73_23
PubMedSearch : Han_2014_Eur.Neurol_73_23
PubMedID: 25376930

Title : Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease - Han_2011_J.Clin.Neurol_7_137
Author(s) : Han HJ , Lee JJ , Park SA , Park HY , Kim JE , Shim YS , Shim DS , Kim EJ , Yoon SJ , Choi SH
Ref : J Clin Neurol , 7 :137 , 2011
Abstract : Han_2011_J.Clin.Neurol_7_137
ESTHER : Han_2011_J.Clin.Neurol_7_137
PubMedSearch : Han_2011_J.Clin.Neurol_7_137
PubMedID: 22087207

Title : Intrathecal neostigmine reduces the zymosan-induced inflammatory response in a mouse air pouch model via adrenomedullary activity: involvement of spinal muscarinic type 2 receptors - Yoon_2005_Neuropharmacol_49_275
Author(s) : Yoon SY , Kwon YB , Kim HW , Roh DH , Kang SY , Kim CY , Han HJ , Kim KW , Yang IS , Beitz AJ , Lee JH
Ref : Neuropharmacology , 49 :275 , 2005
Abstract : Yoon_2005_Neuropharmacol_49_275
ESTHER : Yoon_2005_Neuropharmacol_49_275
PubMedSearch : Yoon_2005_Neuropharmacol_49_275
PubMedID: 15922370